Paracetamol: not as safe as we thought? A systematic literature review of observational studies
Open Access
- 2 March 2015
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 75 (3), 552-559
- https://doi.org/10.1136/annrheumdis-2014-206914
Abstract
Objectives We conducted a systematic literature review to assess the adverse event (AE) profile of paracetamol. Methods We searched Medline and Embase from database inception to 1 May 2013. We screened for observational studies in English, which reported mortality, cardiovascular, gastrointestinal (GI) or renal AEs in the general adult population at standard analgesic doses of paracetamol. Study quality was assessed using Grading of Recommendations Assessment, Development and Evaluation. Pooled or adjusted summary statistics were presented for each outcome. Results Of 1888 studies retrieved, 8 met inclusion criteria, and all were cohort studies. Comparing paracetamol use versus no use, of two studies reporting mortality one showed a dose–response and reported an increased relative rate of mortality from 0.95 (0.92 to 0.98) to 1.63 (1.58 to 1.68). Of four studies reporting cardiovascular AEs, all showed a dose–response with one reporting an increased risk ratio of all cardiovascular AEs from 1.19 (0.81 to 1.75) to 1.68 (1.10 to 2.57). One study reporting GI AEs reported a dose–response with increased relative rate of GI AEs or bleeds from 1.11 (1.04 to 1.18) to 1.49 (1.34 to 1.66). Of four studies reporting renal AEs, three reported a dose–response with one reporting an increasing OR of ≥30% decrease in estimated glomerular filtration rate from 1.40 (0.79 to 2.48) to 2.19 (1.4 to 3.43). Discussion Given the observational nature of the data, channelling bias may have had an important impact. However, the dose–response seen for most endpoints suggests a considerable degree of paracetamol toxicity especially at the upper end of standard analgesic doses.Keywords
This publication has 20 references indexed in Scilit:
- Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular EventsCirculation, 2006
- Lifetime Nonnarcotic Analgesic Use and Decline in Renal Function in WomenArchives of Internal Medicine, 2004
- EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Annals Of The Rheumatic Diseases, 2003
- Analgesic use and change in kidney function in apparently healthy menAmerican Journal of Kidney Diseases, 2003
- A population-based cohort study of mortality among adults prescribed paracetamol in DenmarkJournal of Clinical Epidemiology, 2003
- Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly populationArthritis & Rheumatism, 2002
- Nonnarcotic Analgesic Use and the Risk of Hypertension in US WomenHypertension, 2002
- Frequency of analgesic use and risk of hypertension in younger women.Archives of Internal Medicine, 2002
- Relative Risk of Upper Gastrointestinal Complications among Users of Acetaminophen and Nonsteroidal Anti-Inflammatory DrugsEpidemiology, 2001
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJama-Journal Of The American Medical Association, 2000